白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

已收盘 11-12 16:08:06

12.690

-0.130

-1.01%

最高12.860	最低12.690	成交量128.80万
今开12.860	昨收12.820	日振幅1.33%
总市值206.34亿	流通市值27.91亿	总股本16.26亿
成交额1,639万	换手率0.59%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":12.69,"timestamp":1794470886002,"preClose":12.82,"halted":0,"volume":1288000,"delay":0,"changeRate":-0.01014040561622471,"floatShares":219900000,"shares":1626000000,"eps":2.158447575267889,"marketStatus":"已收盘","change":-0.13,"latestTime":"11-12 16:08:06","open":12.86,"high":12.86,"low":12.69,"amount":16390880,"amplitude":0.013261,"askPrice":12.69,"askSize":106000,"bidPrice":12.68,"bidSize":42000,"shortable":3,"etf":0,"ttmEps":1.5665636096267592,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":12.82,"dividendRate":0.068006,"openAndCloseTimeList":[[1794447000000,1794456000000],[1794459600000,1794470400000]],"volumeRatio":1.30092,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":19.47,"timestamp":1794466800000,"preClose":19.51,"halted":0,"volume":8177000,"delay":0,"premium":"-44.59"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2682205581","title":"股市必读：白云山（600332）11月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2682205581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682205581?lang=zh_cn&edition=full","pubTime":"2026-11-12 02:48","pubTimestamp":1794422893,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘，白云山报收于19.51元，下跌1.06%，换手率0.53%，成交量7.48万手，成交额1.46亿元。公司披露的最新股东户数是截至2026年9月30日的户数，股东数为111,428户。当日关注点交易信息汇总：11月11日主力资金净流入195.57万元，游资资金净流入1173.07万元，散户资金净流出1368.64万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200002545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0096","BK1521","BK1197","BK0028","BK0188","BK0070","00874","BK0097","BK0183","BK0196","BK0239","BK1191","BK0175","BK1606","BK1515","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682957377","title":"白云山：加强市值管理工作，争取给投资者更好的投资回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2682957377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682957377?lang=zh_cn&edition=full","pubTime":"2026-11-11 17:30","pubTimestamp":1794389459,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山11月11日在投资者关系平台上答复投资者关心的问题。请问白云山各管理层，白云山作为国资公司，股价十年下滑，而同期间同行业没有一家公司是这个走势，市值管理口号喊了几年不见对维护市值有什么实际作用，公司分红力度相对可以但是分化后未填权股价一直下滑，是否有必要启动内部责任处罚制度避免投资人无限损失？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100034932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0183","BK0096","BK1197","BK1515","BK0028","BK1521","BK0175","BK1606","BK0196","600332","BK0012","00874","BK0097","BK1191","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682310789","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682310789","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682310789?lang=zh_cn&edition=full","pubTime":"2026-11-11 02:51","pubTimestamp":1794336671,"startTime":"0","endTime":"0","summary":"公司公告汇总广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告广州白云山医药集团股份有限公司于2026年11月9日召开第十届董事会第六次会议，审议通过聘任李文政先生为公司副总经理，任期至本届董事会任期届满。会议还审议通过关于广州医药股份有限公司公开挂牌引入战略投资者并实施定向发行的议案，以及提请召开2026年第二次临时股东会的议案。本次增资扩股已获董事会审议通过，尚需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100006140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0196","BK0175","BK1515","BK0239","BK1606","BK0012","159938","600332","BK0097","BK0188","BK1521","BK0028","BK1191","00874","BK0096","BK1197","09939","BK1574","BK0183","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682393515","title":"白云山（600332）披露子公司拟公开挂牌引入战略投资者并实施定向发行，11月10日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682393515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682393515?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:56","pubTimestamp":1794304598,"startTime":"0","endTime":"0","summary":"截至2026年11月10日收盘，白云山报收于19.72元，较前一交易日下跌0.95%，最新总市值为320.61亿元。该股当日开盘20.0元，最高20.03元，最低19.7元，成交额达1.45亿元，换手率为0.52%。近日，广州白云山医药集团股份有限公司发布《关于子公司公开挂牌引入战略投资者并实施股票定向发行的公告》。本次增资不构成重大资产重组，最终投资者及募资金额存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000036487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0188","BK1191","BK0239","BK1606","00874","BK0175","600332","BK0096","BK1197","BK1515","BK0097","BK0196","BK1521","BK0070","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156697397","title":"白云山（00874）董事会通过多项议案 新聘副总经理并拟引入战投","url":"https://stock-news.laohu8.com/highlight/detail?id=1156697397","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156697397?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:05","pubTimestamp":1794236744,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司11月9日晚间公告称，公司于当日召开第十届董事会第六次会议，11名董事全部到会，会议的召集、召开程序符合《公司法》及《公司章程》规定。会议审议并一致通过以下三项议案：。其目前未持有公司股份，与主要股东及管理层不存在关联关系。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113738193","title":"白云山(00874)披露广州医药拟增资扩股方案 最高募资60亿元、公司持股不低于53.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113738193","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113738193?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:52","pubTimestamp":1794235929,"startTime":"0","endTime":"0","summary":"2026年11月9日，白云山公告称，其附属公司广州医药股份有限公司已获董事会批准，拟通过广州产权交易所公开挂牌方式引入不超过15家战略投资者，并实施定向发行股票。增资完成后，白云山对广州医药的持股比例将由90.92%稀释至不低于53.23%，仍保持控股地位，合并报表范围不变。截至公告日，广州医药已完成预挂牌20个工作日，正式挂牌期不少于20个工作日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682004938","title":"A股公告精选 | 发行股份及支付现金收购钰泰半导体 艾为电子(688798.SH)11月10日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2682004938","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682004938?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:16","pubTimestamp":1794226563,"startTime":"0","endTime":"0","summary":"今日聚焦1、艾为电子：拟发行股份及支付现金收购钰泰半导体股权，11月10日起停牌艾为电子公告称，公司正在筹划以发行股份及支付现金的方式购买钰泰半导体股份有限公司股权并募集配套资金，经初步测算可能构成重大资产重组，不会导致实际控制人发生变更，不构成重组上市;因事项尚存在不确定性，公司股票及可转债“艾为转债”自2026年11月10日开市起停牌并暂停转股，预计停牌时间不超过10个交易日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002124","688117","BK0188","301302","BK0028","300347","LU1820825898.SGD","00874","688798","BK0175","BK0070","BK0240","BK0096","BK0214","BK0239","BK0097","BK0209","BK0183","600332","BK0196","BK0012","BK0231","BK0077","BK0216","300892","03347","LU1146622755.USD","BK0174","BK0195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682105804","title":"白云山：子公司广州医药拟公开挂牌引入战投并定向发行股票募资不超60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682105804","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682105804?lang=zh_cn&edition=full","pubTime":"2026-11-09 19:22","pubTimestamp":1794223368,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600332","BK0183","159938","BK0175","09939","BK1161","BK0097","BK0070","BK0012","BK0196","BK0028","BK1197","BK1521","BK1191","00874","BK1574","BK0096","BK0239","BK0188","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682879031","title":"【券商聚焦】长城证券维持白云山（00874）增持评级 指工业板块恢复是利润修复前提","url":"https://stock-news.laohu8.com/highlight/detail?id=2682879031","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682879031?lang=zh_cn&edition=full","pubTime":"2026-11-09 14:01","pubTimestamp":1794204105,"startTime":"0","endTime":"0","summary":"金吾财讯 | 长城证券发布研报指，白云山 2026Q3收入平稳但利润承压，品牌与渠道举措蓄力。前三季度营收620.76亿元，同比增0.76%；归母净利润24.92亿元，同比降24.73%。报告指出，Q3收入增长主要靠商业端拉动，工业板块仍有压力：大南药受行业政策影响，天然饮品受凉茶市场走弱拖累。报告认为，工业板块恢复是利润端修复前提。报告称，公司四大业务板块协同，医药商业提供稳健现金流，大南药有望逐步企稳，研发管线及国际化布局打开长期空间。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995522","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDVL","KCE","PWV","TVAL","IJH","VUSV","PJFV","600332","ASLV","002939","SDVY","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680722775","title":"白云山（600332）披露证券变动月报表，11月03日股价上涨1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680722775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680722775?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:10","pubTimestamp":1793715020,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，白云山报收于20.25元，较前一交易日上涨1.55%，最新总市值为329.22亿元。该股当日开盘19.96元，最高20.28元，最低19.92元，成交额达2.55亿元，换手率为0.9%。近日，广州白云山医药集团股份有限公司披露《证券变动月报表》。公告显示，截至2026年10月31日，公司H股和A股的法定注册资本、已发行股份及库存股份数目均无变动。A股类别于上交所上市，证券代码600332，已发行股份为1,405,890,949股，库存股为0。本月底注册股本总额为人民币1,625,790,949元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300045096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","161027","BK1515","BK1521","BK0183","BK0012","BK0188","BK1606","BK1197","BK0070","BK0097","00874","BK0175","BK0028","600332","BK0196","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177790188","title":"白云山10月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1177790188","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177790188?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:36","pubTimestamp":1793694968,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司于2026年11月3日发布10月股份变动月报表，报告期为截至2026年10月31日止。月报显示，期内公司注册股本及已发行股份均未发生变动，股本总体保持稳定。根据公告，白云山的注册股本包括H股与A股两类。截至10月末，上市H股与A股的已发行股数与上月底相同，H股、A股均为零库存股，无新增发行、购回、注销或转让记录。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680338719","title":"上广州白云山请留意！索道今起停运，恢复时间另行公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2680338719","media":"羊城晚报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680338719?lang=zh_cn&edition=full","pubTime":"2026-11-03 12:38","pubTimestamp":1793680680,"startTime":"0","endTime":"0","summary":"根据广州市白云山风景名胜区公告，为配合索道站房品质提升工程，白云山索道自2026年11月3日起停运，恢复运营时间将根据工程进度在白云山公众号发布。计划前往白云山的游客，出发前请留意相关公告，提前安排登山方式和游览路线。其中，白云山南门观光车将根据客流变化动态调整运营班次，高峰期加密发车、平峰期平稳运转，精准匹配客流波峰波谷，缩短游客候车时间，缓解客流滞留。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-11-03/doc-inixmsvy6701293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK1515","BK1521","BK1606","BK0188","BK0239","BK1191","BK1197","BK0070","BK0175","BK0196","600332","BK0028","BK0096","BK0183","BK0097","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680200644","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680200644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680200644?lang=zh_cn&edition=full","pubTime":"2026-11-02 04:39","pubTimestamp":1793565549,"startTime":"0","endTime":"0","summary":"公司公告汇总广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局核准签发的甲苯磺酸索拉非尼片《药品注册证书》，该药品适用于不能手术的晚期肾细胞癌、肝细胞癌及甲状腺癌；注册分类为化学药品4类；上市许可持有人和生产企业均为白云山制药总厂；截至目前，该项目累计研发投入约1874.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0183","BK0239","BK0196","BK0028","00874","BK1161","BK1521","BK0070","BK0012","BK0096","BK1191","159938","BK1606","BK0188","BK1574","BK1515","600332","BK1197","09939","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226778","title":"白云山（600332）10月30日主力资金净卖出1376.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226778?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:20","pubTimestamp":1793406033,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，白云山报收于19.61元，上涨1.29%，换手率0.7%，成交量9.88万手，成交额1.94亿元。10月30日的资金流向数据方面，主力资金净流出1376.07万元，占总成交额7.11%，游资资金净流出1062.69万元，占总成交额5.49%，散户资金净流入2438.77万元，占总成交额12.6%。近5日资金流向一览见下表：白云山融资融券信息显示，融资方面，当日融资买入1007.03万元，融资偿还1768.68万元，融资净偿还761.65万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK1606","600332","BK1515","BK1197","BK1521","BK0183","BK0188","BK1191","BK0097","BK0175","BK0196","BK0070","00874","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679822555","title":"白云山（600332）2026年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2679822555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679822555?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:22","pubTimestamp":1793402578,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期白云山发布2026年三季报。根据财报显示，白云山增收不增利。截至本报告期末，公司营业总收入620.76亿元，同比上升0.76%，归母净利润24.92亿元，同比下降24.73%。持有白云山最多的基金为中药ETF汇添富，目前规模为21.18亿元，最新净值0.9459，较上一交易日上涨1.08%，近一年下跌11.42%。本文数据来源于白云山2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100015712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1197","BK0070","BK1521","BK0183","00874","BK0188","BK1191","BK0012","BK1515","BK0097","BK0239","BK0196","BK0096","BK0175","BK1606","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679054474","title":"白云山：推动基石业务板块提质增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2679054474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679054474?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:18","pubTimestamp":1793269097,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山(600332)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司利润下滑，股价创新低，显然是经营出了问题。要么管理层提出有用的应对措施，要么换人白云山回复：尊敬的投资者您好，感谢您的关注！公司将推动基石业务板块提质增效，培育新动能促发展；继续推动创新转型，聚力锻强科技引擎；进一步推进国际化进程，强化资本运作，主动释放公司价值。公司将不断加强市值管理工作，争取给投资者更好的投资回报。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900043458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1197","BK1515","BK0012","BK0183","BK0096","BK1191","BK1521","BK1606","BK0188","BK0028","BK0239","00874","BK0097","600332","BK0175","BK0070","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124850909","title":"白云山（00874）获批甲苯磺酸索拉非尼片注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1124850909","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124850909?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:55","pubTimestamp":1793264133,"startTime":"0","endTime":"0","summary":"2026年10月29日，广州白云山医药集团股份有限公司公告称，其分公司广州白云山医药集团股份有限公司白云山制药总厂已收到国家药品监督管理局核准签发的《药品注册证书》，产品为甲苯磺酸索拉非尼片。白云山制药总厂于2025年7月24日提交该品种上市注册申请，并于2025年7月30日获得受理。本次获得注册证书后，白云山制药总厂将按相关要求及市场需求安排生产。截至公告日，白云山制药总厂在该项目上累计投入研发费用约1,874.83万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679758384","title":"白云山(00874.HK)分公司收到关于甲苯磺酸索拉非尼片的《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679758384","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679758384?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:53","pubTimestamp":1793264023,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","BK1191","BK1606","00874","BK1521","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679478908","title":"白云山：甲苯磺酸索拉非尼片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2679478908","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679478908?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:14","pubTimestamp":1793261640,"startTime":"0","endTime":"0","summary":"南财智讯10月29日电，白云山公告，公司分公司白云山制药总厂收到国家药品监督管理局签发的甲苯磺酸索拉非尼片《药品注册证书》。该产品用于治疗不能手术的晚期肾细胞癌，无法手术或远处转移的肝细胞癌，以及局部复发或转移的进展性的放射性碘难治性分化型甲状腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610293914129766.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610293914129766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","BK0175","BK0028","BK0196","BK1197","BK1515","BK0070","600332","BK0012","BK0183","BK1191","BK1606","BK0097","00874","BK0239","BK1521","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679418057","title":"图解白云山三季报：第三季度单季净利润同比下降50.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679418057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679418057?lang=zh_cn&edition=full","pubTime":"2026-10-29 02:20","pubTimestamp":1793211621,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山2026年三季报显示，前三季度公司主营收入620.76亿元，同比上升0.76%；归母净利润24.92亿元，同比下降24.73%；扣非净利润22.24亿元，同比下降22.5%；其中2026年第三季度，公司单季度主营收入199.85亿元，同比上升1.08%；单季度归母净利润3.96亿元，同比下降50.17%；单季度扣非净利润2.85亿元，同比下降57.04%；负债率52.53%，投资收益2.73亿元，财务费用2.69亿元，毛利率16.32%。财报数据概要请见下图:本文数据来源于白云山2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","600332"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.031},{"period":"1month","weight":-0.0361},{"period":"3month","weight":-0.1382},{"period":"6month","weight":-0.1802},{"period":"1year","weight":-0.3186},{"period":"ytd","weight":-0.232}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0425},{"period":"6month","weight":-0.0634},{"period":"1year","weight":-0.0892},{"period":"ytd","weight":-0.0513}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009908},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058543},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049537},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081866},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044368},{"month":6,"riseRate":0.482759,"avgChangeRate":0.018954},{"month":7,"riseRate":0.448276,"avgChangeRate":-0.011349},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.040031},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.01093},{"month":10,"riseRate":0.413793,"avgChangeRate":0.002782},{"month":11,"riseRate":0.433333,"avgChangeRate":0.00801},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023642}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}